Hello John,
Transcranial Magnetic Stimulation (TMS) is cleared by the United States Food and Drug Administration for difficult-to-treat depression, obsessive-compulsive disorder, migraine headaches, and smoking cessation, but patients and families may not be familiar with it.
Join us for our next webinar, Thursday, Feb. 17 at 3 p.m. EST, and get the answers from our special guest, Joseph J. Taylor, M.D., Ph.D., medical director of TMS in the Center for Brain Circuit Therapeutics at Brigham and Women’s Hospital and an instructor in psychiatry at Harvard Medical School.
Dr. Taylor is a psychiatrist and neuroscientist with expertise in Interventional psychiatry. First, Dr. Taylor will introduce TMS in an accessible manner. Next, Dr. Taylor will discuss how TMS is currently used clinically. Finally, Dr. Taylor will share new developments in TMS that might make it more effective and more useful for a wide variety of neuropsychiatric illnesses.
Don’t miss this fascinating discussion, moderated by Treatment Advocacy Center Director of Research and Public Affairs Elizabeth Sinclair Hancq.
Join us!
Best,
Treatment Advocacy Center
